Learning Objectives:
1. To evaluate if patients with chronic kidney disease and a high risk of progression, urate-lowering treatment with allopurinol.
2. To determine clinical significance of study results.
Session date:
03/05/2021 - 12:00pm to 1:00pm CST
Location:
Zoom meeting
5700 S. Maryland
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Juhi Bhargava, MD